Conolidine’s analgesic outcomes stem from its interaction with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors while in the central nervous method, conolidine modulates alternate molecular targets. A Science Advances analyze located that conolidine interacts Along with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid https://roberts086rsz0.wikiap.com/user